Cargando…

1,25-(OH)(2)D(3)/Vitamin D receptor alleviates systemic lupus erythematosus by downregulating Skp2 and upregulating p27

BACKGROUND: Recent evidence has suggested that the 1,25(OH)(2)D(3)/Vitamin D receptor (VDR) acts to suppress the immune response associated with systemic lupus erythematosus (SLE), a serious multisystem autoimmune disease. Hence, the aim of the current study was to investigate the mechanism by which...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Dan, Fang, Yu-Xuan, Wu, Xia, Tan, Wei, Zhou, Wei, Zhang, Yu, Liu, Yan-Qing, Li, Guo-Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905035/ https://www.ncbi.nlm.nih.gov/pubmed/31823770 http://dx.doi.org/10.1186/s12964-019-0488-2

Ejemplares similares

Vitamin D (1,25-(OH)(2)D(3)) Improves Endothelial Progenitor Cells Function via Enhanced NO Secretion in Systemic Lupus Erythematosus
por: Huang, Zhenhua, et al.
Publicado: (2020)

Association among plasma 1,25(OH)(2)D, ratio of 1,25(OH)(2)D to 25(OH)D, and prostate cancer aggressiveness
por: Ramakrishnan, Swathi, et al.
Publicado: (2019)

Effects of 1,25(OH)(2)D(3) and vitamin D receptor on peripheral CD4(+)/CD8(+) double‐positive T lymphocytes in a mouse model of systemic lupus erythematosus
por: Ding, Yan, et al.
Publicado: (2017)

Vitamin D and 1,25(OH)(2)D Regulation of T cells
por: Cantorna, Margherita T., et al.
Publicado: (2015)

MicroRNA-125b mediates Interferon-γ-induced downregulation of the vitamin D receptor in systemic lupus erythematosus
por: Gu, Yihong, et al.
Publicado: (2023)

Expression of TXNIP in Cancer Cells and Regulation by 1,25(OH)(2)D(3): Is It Really the Vitamin D(3) Upregulated Protein?
por: Abu el Maaty, Mohamed A., et al.
Publicado: (2018)

Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)(2)D, but No Difference in Ratio of 25(OH)D/24,25(OH)(2)D and FGF23 Concentrations
por: Vlot, Mariska C, et al.
Publicado: (2019)

The Amelioration of Renal Damage in Skp2-Deficient Mice Canceled by p27 (Kip1) Deficiency in Skp2(−/−) p27(−/−) Mice
por: Suzuki, Sayuri, et al.
Publicado: (2012)

1,25-Dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) Signaling Capacity and the Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer (NSCLC): Implications for Use of 1,25(OH)(2)D(3) in NSCLC Treatment
por: Upadhyay, Santosh Kumar, et al.
Publicado: (2013)

Downregulation of decidual SKP2 is associated with human recurrent miscarriage
por: Lv, Shijian, et al.
Publicado: (2021)

1,25(OH)(2)D(3) Protects Liver Fibrosis Through Decreasing the Generation of TH17 Cells
por: Gu, Lei, et al.
Publicado: (2017)

Quinacrine upregulates p21/p27 independent of p53 through autophagy-mediated downregulation of p62-Skp2 axis in ovarian cancer
por: Jung, DeokBeom, et al.
Publicado: (2018)

Vitamin D (1,25(OH)(2)D3) induces α-1-antitrypsin synthesis by CD4(+) T cells, which is required for 1,25(OH)(2)D3-driven IL-10
por: Dimeloe, Sarah, et al.
Publicado: (2019)

Antidepressants differentially related to 1,25-(OH)(2) vitamin D(3) and 25-(OH) vitamin D(3) in late-life depression
por: Oude Voshaar, R C, et al.
Publicado: (2014)

Does Sevelamer Hydrochloride (Renagel) Influence 25(Oh)D3 and 1,25(Oh)2D3 Level in Haemodialysis Patients?
por: Strózecki, Pawel, et al.
Publicado: (2005)

25(OH)D(3) and 1.25(OH)(2)D(3) inhibits TNF-α expression in human monocyte derived macrophages
por: Rafique, Aisha, et al.
Publicado: (2019)

MON-LB74 The Problem of Measuring 1,25(OH)2 Vitamin D in Patients With High Levels of 25(OH) Vitamin D
por: Vieira, Jose Gilberto, et al.
Publicado: (2020)

Circulatory 25(OH)D and 1,25(OH)(2)D as differential biomarkers between multiple system atrophy and Parkinson's disease patients
por: Ogura, Hiromu, et al.
Publicado: (2021)

25(OH)D-but not 1,25(OH)(2)D–Is an independent risk factor predicting graft loss in stable kidney transplant recipients
por: Zeng, Shufei, et al.
Publicado: (2023)

1,25(OH)(2)D(3) downregulates the Toll-like receptor 4-mediated inflammatory pathway and ameliorates liver injury in diabetic rats
por: Wang, H., et al.
Publicado: (2015)

Effects of 1,25(OH)(2)D(3) and 25(OH)D(3) on C2C12 Myoblast Proliferation, Differentiation, and Myotube Hypertrophy
por: van der Meijden, K., et al.
Publicado: (2016)

The metabolism of 1,25(OH)(2)D(3) in clinical and experimental kidney disease
por: Turner, Mandy E., et al.
Publicado: (2022)

The role of vitamin D-synthesizing enzyme CYP27B1 in systemic lupus erythematosus
por: LUO, Man, et al.
Publicado: (2022)

25(OH)D and 1,25(OH)D vitamin D fails to predict sepsis and mortality in a prospective cohort study
por: Ratzinger, Franz, et al.
Publicado: (2017)

Anticancer activity of 1,25-(OH)(2)D(3) against human breast cancer cell lines by targeting Ras/MEK/ERK pathway
por: Zheng, Wei, et al.
Publicado: (2019)

The protective effect of iodide intake adjustment and 1,25(OH)(2)D(3) supplementation in rat offspring following excess iodide intake
por: Wang, Ying, et al.
Publicado: (2020)

1,25(OH)(2)D(3) inhibits osteogenic differentiation through activating β-catenin signaling via downregulating bone morphogenetic protein 2
por: Han, Xiaofeng, et al.
Publicado: (2020)

MYC Modulation around the CDK2/p27/SKP2 Axis
por: Hydbring, Per, et al.
Publicado: (2017)

Roles of the Skp2/p27 axis in the progression of chronic nephropathy
por: Suzuki, Sayuri, et al.
Publicado: (2012)

Vitamin D and the Ability to Produce 1,25(OH)(2)D Are Critical for Protection from Viral Infection of the Lungs
por: Arora, Juhi, et al.
Publicado: (2022)

Differential and Overlapping Effects of 20,23(OH)(2)D3 and 1,25(OH)(2)D3 on Gene Expression in Human Epidermal Keratinocytes: Identification of AhR as an Alternative Receptor for 20,23(OH)(2)D3
por: Slominski, Andrzej T., et al.
Publicado: (2018)

The 25(OH)D3, but Not 1,25(OH)2D3 Levels Are Elevated in IBD Patients Regardless of Vitamin D Supplementation and Do Not Associate with Pain Severity or Frequency
por: Zielińska, Anna, et al.
Publicado: (2021)

The Impact of Estradiol and 1,25(OH)2D3 on Metabolic Syndrome in Middle-Aged Taiwanese Males
por: Cheng, Kai-Hung, et al.
Publicado: (2013)

26,26,26,27,27,27-Hexadeuterated-1,25-Dihydroxyvitamin D(3) (1,25D-d(6)) As Adjuvant of Chemotherapy in Breast Cancer Cell Lines
por: Seoane, Samuel, et al.
Publicado: (2013)

Cryo-EM structure of SKP1-SKP2-CKS1 in complex with CDK2-cyclin A-p27KIP1
por: Rowland, Rhianna J., et al.
Publicado: (2023)

Diosgenin Exerts Antitumor Activity via Downregulation of Skp2 in Breast Cancer Cells
por: Liu, Yanling, et al.
Publicado: (2020)

1,25(OH)(2)D(3) Promotes the Efficacy of CD28 Costimulation Blockade by Abatacept
por: Gardner, David H., et al.
Publicado: (2015)

1,25(OH)(2)D(3) dependent overt hyperactivity phenotype in klotho-hypomorphic mice
por: Leibrock, Christina B., et al.
Publicado: (2016)

Nobiletin downregulates the SKP2-p21/p27-CDK2 axis to inhibit tumor progression and shows synergistic effects with palbociclib on renal cell carcinoma
por: Chen, Tingting, et al.
Publicado: (2021)

Recruitment, augmentation and apoptosis of rat osteoclasts in 1,25-(OH)(2)D(3) response to short-term treatment with 1,25-dihydroxyvitamin D(3)in vivo
por: Miao, Dengshun, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_gn8m7i3d3g5pi9l66sbolris9i